Nadza Tokaca
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Acquired ERBB2 Amplification and Overexpression as On-Target Resistance Mechanisms to Zongertinib With Subsequent Response to Trastuzumab-Deruxtecan: A Case Report.
Journal: JTO clinical and research reports
Published: March 09, 2026
Stereotactic Radiosurgery (SRS) for Small Cell Lung Cancer (SCLC) brain metastases: a real-world UK tertiary centre experience.
Journal: The British journal of radiology
Published: August 15, 2025
Durvalumab in locally advanced unresectable non-small cell lung cancer - Benchmarking real-world outcomes in England against published trial data.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 04, 2025
Grade 3 and grade 4 cutaneous toxicities in patients with multiple solid tumour types receiving checkpoint inhibitor therapy: an observational study. The experience of a single large specialist institution.
Journal: Clinical and experimental dermatology
Published: November 13, 2024
Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future care.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 07, 2024
Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case Report.
Journal: JTO clinical and research reports
Published: August 02, 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: November 17, 2023
Squamous Non-Small-Cell Lung Cancer Molecularly Reclassified as Transdifferentiated Prostate Cancer Due to Identification of TMPRSS2-ERG Translocation With SOX2 Amplification.
Journal: JCO oncology practice
Published: August 26, 2020
Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center Experience.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 17, 2017
Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026